iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 31.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,844 shares of the financial services provider’s stock after selling 1,279 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $376,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at about $29,000. HHM Wealth Advisors LLC grew its holdings in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares during the period. Bradley & Co. Private Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $32,000. Newbridge Financial Services Group Inc. purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB opened at $134.19 on Friday. The stock has a market capitalization of $6.34 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. The business has a 50-day moving average of $136.25 and a two-hundred day moving average of $139.96. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.